The findings of our study therefore not only help reassure the millions of patients relying on semaglutide for diabetes management, but, if confirmed, might also have significant implications for public health in terms of reducing cognitive deficit and smoking rates among patients with diabetes. While the studys robust methodology and extensive data provide strong evidence, researchers say further investigation is needed and that it remains unclear how semaglutide may be having these effects
Explore the potential connection between semaglutide, a GLP-1 receptor agonist, and insomnia
While not indicated for weight loss, participants treated with Mounjaro lost between 5.5 kg (12 lb) and 11 kg (25 lb) on average
Key concerns remain: muscle and bone loss with sustained weight reduction, weight regain after discontinuation, and long-term adherence data still limited to under 3 years
Eventually, the caloric deficit created by tirzepatide-induced appetite suppression narrows to the point where weight loss slows or stops
This option may be preferred by individuals seeking a simple, stress-free alternative to injections
.webp)
